CoChat

The role of the microbiome in exacerbations of chronic lung diseases

Open access
Dickson, Robert P, Martinez, Fernando J, Huffnagle, Gary B · 2014 · The Lancet

The DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index.

Abstract

Culture-independent microbiological techniques have shown a previously unappreciated complexity to the bacterial microbiome of the respiratory tract that forces reconsideration of the interactions between host, bacteria, and the pathogenesis of exacerbations of chronic lung disease. The composition of the lung microbiome is determined by microbial immigration, elimination, and relative growth rates of its members. All these factors change dramatically in chronic lung disease and further during exacerbations. Exacerbations lack the features of bacterial infections, including increased bacterial burden and decreased diversity of microbial communities. We propose that exacerbations are occasions of respiratory tract dysbiosis--a disorder of the respiratory tract microbial ecosystem with negative effects on host biology. Respiratory tract dysbiosis provokes a dysregulated host immune response, which in turn alters growth conditions for microbes in airways, promoting further dysbiosis and perpetuating a cycle of inflammation and disordered microbiota. Differences in the composition of baseline respiratory tract microbiota might help to explain the so-called frequent-exacerbator phenotype observed in several disease states, and might provide novel targets for therapeutic intervention.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(14)61136-3

Cites

143 of 143 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 143 references

Cited by

See all 550

Metadata

Authors
Dickson, R. P., Martinez, F. J., & Huffnagle, G. B.
Affiliations
University of Michigan (US)
Corresponding author
Huffnagle, Gary B
Venue
The Lancet
Publisher
Elsevier BV
Published
2014-08
Volume
384
Issue
9944
Pages
691-702
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2087537704
Cited by
495
References
141
Citations by year
2026: 16 · 2025: 42 · 2024: 64 · 2023: 34 · 2022: 46 · 2021: 56 · 2020: 61 · 2019: 29 · 2018: 40 · 2017: 42 · 2016: 31 · 2015: 29 · 2014: 4
FWCI
6.04
Type
journal article
Language
en
Open access
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
NIH (T32HL00774921 (RPD), U01HL098961 (GBH), R01HL114447 (GBH, FJM))
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
Keywords
lung microbiome, chronic lung disease, exacerbations, host-microbe interactions, immune dysregulation, inflammation, frequent exacerbators, bacterial diversity, microbiota-targeted therapy
MeSH terms
Bacterial Infections, Bacteriological Techniques, Chronic Disease, Humans, Lung Diseases, Respiratory Tract Infections, Risk Factors, Host-Pathogen Interactions, Microbiota

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The role of the microbiome in exacerbations of chronic lung diseases. https://app.cochat.ai/papers/10.1016/s0140-6736(14)61136-3
The paper
Dickson, R. P., Martinez, F. J., & Huffnagle, G. B. (2014). The role of the microbiome in exacerbations of chronic lung diseases. The Lancet. https://doi.org/10.1016/s0140-6736(14)61136-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.